XML 100 R119.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-Based Compensation, Summary of Stock-Based Compensation Expense (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Share-Based Compensation Arrangement by Share-based Payment Award          
Shares available for grant     3,383,998    
Payout percentage assumption     200.00%    
Stock-based compensation expense     $ 55 $ 80 $ 105
Income tax benefit for stock-based compensation arrangements $ 11 $ (7) 24 29 37
Tax benefit realized from exercise or vesting of stock-based compensation awards 54 3 46 42 30
Share-based compensation expense $ 28 $ (18)      
Stock appreciation rights (SARs)          
Share-Based Compensation Arrangement by Share-based Payment Award          
Exercised stock appreciation rights (shares) 300,000 200,000      
Stock-based compensation expense     $ 15 35 61
Vesting period     3 years    
Life of award (years)     7 years    
Cash used to settle awards $ 20 $ 4 $ 31 37 $ 38
Amount recorded in other current liabilities 55   $ 60 $ 76  
Share-based compensation expense [1] $ 15 $ (18)      
Stock-based compensation awards other than options, Outstanding          
Outstanding at January 1, 2014 1,089,000 2,196,000 2,196,000    
Exercised     (955,000)    
Forfeited     (152,000)    
Outstanding at December 31, 2014     1,089,000 2,196,000  
Vested or expected to vest at December 31, 2014     1,089,000    
Exercisable at December 31, 2014     1,089,000    
Equity Instruments, Additional Disclosures          
Weighted average exercise price, outstanding at January 1, 2014 $ 18.16 $ 24.53 $ 24.53    
Weighted average exercise price, exercised     28.09    
Weighted average exercise price, forfeited     47.82    
Weighted average exercise price, outstanding at December 31, 2014     18.16 $ 24.53  
Weighted average exercise price, vested or expected to vest at December 31, 2014     18.16    
Weighted average exercise price, exercisable at December 31, 2014     $ 18.16    
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms     1 year 2 months 12 days 1 year 6 months 4 days  
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms     1 year 2 months 12 days 1 year 6 months 4 days  
Weighted average remaining contractual term, other than options vested or expected to vest     1 year 2 months 12 days    
Weighted average remaining contractual term, other than options exercisable at December 31, 2014     1 year 2 months 12 days    
Fair Value Assumptions and Methodology          
Expected life from date of grant (years)     7 years 7 years 7 years
Expected volatility     58.00% 61.00% 57.00%
Expected dividend yield     1.00% 2.00% 1.00%
Risk-free interest rate     0.30% 0.20% 0.20%
Performance share awards          
Share-Based Compensation Arrangement by Share-based Payment Award          
Payout percentage assumption     100.00%    
Stock-based compensation expense     $ 17 $ 20 $ 13
Vesting period     3 years    
Share-based compensation expense [2] $ 4 $ (3)      
Vesting percentage lower limit     0.00%    
Vesting percentage upper limit     200.00%    
Performance period     3 years    
Nonvested awards, total compensation cost not yet recognized     $ 9    
Total compensation cost not yet recognized, period for recognition     1 year 8 months 12 days    
Weighted average payout percentage     114.00%    
Stock-based compensation awards other than options, Outstanding          
Outstanding at January 1, 2014 615,000 805,000 805,000    
Granted 100,000   383,000    
Vested     (444,000)    
Forfeited     (129,000)    
Outstanding at December 31, 2014     615,000 805,000  
Equity Instruments, Additional Disclosures          
Weighted average grant date fair value, nonvested at January 1, 2014 $ 42.82 $ 36.70 $ 36.70    
Weighted average grant date fair value, granted $ 117.96   54.42 $ 53.81 $ 30.98
Weighted average grant date fair value, vested     42.39    
Weighted average grant date fair value, forfeited     40.55    
Weighted average grant date fair value, nonvested at December 31, 2014     $ 42.82 $ 36.70  
Intrinsic value     $ 46 $ 47  
Fair Value Assumptions and Methodology          
Expected volatility     44.00% 45.00% 45.00%
Expected dividend yield     0.00% 1.00% 1.00%
Risk-free interest rate     0.50% 0.70% 0.40%
Market stock units          
Share-Based Compensation Arrangement by Share-based Payment Award          
Payout percentage assumption     100.00%    
Stock-based compensation expense     $ 17 $ 17 $ 13
Vesting period     3 years    
Share-based compensation expense [3] $ 5 $ 3      
Vesting percentage lower limit     50.00%    
Vesting percentage upper limit     200.00%    
Performance period     3 years    
Nonvested awards, total compensation cost not yet recognized     $ 14    
Total compensation cost not yet recognized, period for recognition     1 year 4 months 24 days    
Weighted average payout percentage     172.00%    
Market Condition Market Stock Units     50.00%    
Stock-based compensation awards other than options, Outstanding          
Outstanding at January 1, 2014 1,331,000 1,391,000 1,391,000    
Granted 400,000   823,000    
Vested     (706,000)    
Forfeited     (177,000)    
Outstanding at December 31, 2014     1,331,000 1,391,000  
Equity Instruments, Additional Disclosures          
Weighted average grant date fair value, nonvested at January 1, 2014 $ 51.84 $ 44.03 $ 44.03    
Weighted average grant date fair value, granted $ 114.57   57.60 $ 66.11 $ 33.93
Weighted average grant date fair value, vested     44.35    
Weighted average grant date fair value, forfeited     47.13    
Weighted average grant date fair value, nonvested at December 31, 2014     $ 51.84 $ 44.03  
Intrinsic value     $ 99 $ 81  
Fair Value Assumptions and Methodology          
Expected volatility     44.00% 45.00% 51.00%
Expected dividend yield     2.00% 1.00% 0.00%
Risk-free interest rate     0.70% 0.40% 0.30%
Restricted common stock          
Share-Based Compensation Arrangement by Share-based Payment Award          
Stock-based compensation expense     $ 3 $ 2 $ 6
Performance period     3 years    
Nonvested awards, total compensation cost not yet recognized     $ 5    
Total compensation cost not yet recognized, period for recognition     2 years 3 months 18 days    
Vested in period, total fair value     $ 2 $ 18 $ 14
Fair value of nonvested awards     $ 9    
Stock-based compensation awards other than options, Outstanding          
Outstanding at January 1, 2014 128,000 98,000 98,000    
Granted     74,000    
Vested     (27,000)    
Forfeited     (17,000)    
Outstanding at December 31, 2014     128,000 98,000  
Equity Instruments, Additional Disclosures          
Weighted average grant date fair value, nonvested at January 1, 2014 $ 51.04 $ 35.88 $ 35.88    
Weighted average grant date fair value, granted     61.76 $ 53.15 $ 30.78
Weighted average grant date fair value, vested     44.30    
Weighted average grant date fair value, forfeited     21.94    
Weighted average grant date fair value, nonvested at December 31, 2014     $ 51.04 $ 35.88  
Stock options          
Share-Based Compensation Arrangement by Share-based Payment Award          
Annual vesting percentage     33%    
Life of option (years)     ten years    
Stock-based compensation expense     $ 0 $ 0 $ 2
Stock-based compensation awards, options, outstanding          
Outstanding at January 1, 2014 704,000 1,410,000 1,410,000    
Granted     0 0  
Exercised     (696,000)    
Forfeited     (10,000)    
Outstanding at December 31, 2014     704,000 1,410,000  
Vested or expected to vest at December 31, 2014     704,000    
Exercisable at December 31, 2014     704,000    
Equity Instruments, Additional Disclosures          
Weighted average stock option exercise price, outstanding at January 1, 2014 $ 31.05 $ 28.97 $ 28.97    
Weighted average stock option exercise price, exercised     26.98    
Weighted average stock option exercise price, forfeited or expired     20.99    
Weighted average stock option exercise price, outstanding at December 31, 2014     31.05 $ 28.97  
Weighted average stock option exercise price, vested or expect to vest at December 31, 2014     31.05    
Weighted average stock option exercise price, exercisable at December 31, 2014     $ 31.05    
Aggregate stock option intrinsic value, outstanding at January 1, 2014 $ 30 $ 42 $ 42    
Aggregate stock option intrinsic value, outstanding at December 31, 2014     30 $ 42  
Aggregate stock option intrinsic value, vested or expected to vest at December 31, 2014     30    
Aggregate stock option intrinsic value, exercisable at December 31, 2014     $ 30    
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2     3 years 1 month 6 days 3 years 4 months 24 days  
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2     3 years 1 month 6 days 3 years 4 months 24 days  
Weighted average remaining contractual term, stock options vested or expected to vest at December 31, 2014     3 years 1 month 6 days    
Weighted average remaining contractual term, stock options exercisable at December 31, 2014     3 years 1 month 6 days    
Total intrinsic value, stock options exercised     $ 25 $ 48 28
Tax benefit from stock options exercised     9    
Other stock-based compensation          
Share-Based Compensation Arrangement by Share-based Payment Award          
Stock-based compensation expense     $ 3 $ 6 $ 10
Other stock-based awards [Member]          
Share-Based Compensation Arrangement by Share-based Payment Award          
Share-based compensation expense [4] $ 4 $ 0      
[1] We paid cash of $20 million and $4 million to settle 0.3 million and 0.2 million SARs that were exercised during the three months ended March 31, 2015 and 2014, respectively. We had $55 million and $60 million recorded in accrued liabilities associated with our SARs awards at March 31, 2015 and December 31, 2014, respectively.
[2] We granted 0.1 million market condition performance share awards at a weighted average grant date fair value of $117.96 per share under the amended and restated 2011 Long-Term Incentive Plan (“2011 Plan”) during the three months ended March 31, 2015.
[3] We granted 0.4 million market stock units at a weighted average grant date fair value of $114.57 per unit under the 2011 Plan during the three months ended March 31, 2015.
[4] We have aggregated expenses for certain award types as they are not considered significant.